TOOLS ON EMERGING DISEASES RESEARCH
ANTIGENS, ANTIBODIES AND MORE
The Native Antigen Company offers a range of reagents that enable research into vaccine development and diagnostics for emerging and endemic infectious diseases. Key product ranges include antigens, virus-like particles (VLPs), antibodies, BacTrace® antigens and antibodies, virus receptors, immunoassays, molecular controls, neutralization assay development kits, conjugation kits, and more.
Literatures available on request
- Flavivirus research
- Vector-borne Bunyaviridae research
- Influenza research
- Featured products from The Native Antigen Company
Fill in the below form to request literatures.
All products listed on this site and sold through LAB-A-PORTER Limited are for research use only (RUO). Not for human use. Not for therapeutic or diagnostic use.
ABOUT THE NATIVE ANTIGEN COMPANY
One Of The World’s Leading Suppliers Of Infectious Disease Research Reagents.
Founded in 2010, The Native Antigen Company has rapidly become one of the world’s leading suppliers of infectious disease reagents. Their portfolio of reagents continues to expand rapidly, and they are widely acknowledged to be a primary source of reagents and kits for the study of emerging diseases. In July of 2020, The Native Antigen Company was acquired by The LGC Group, a global leader in the life sciences sector, and is now part of the LGC Clinical Diagnostics business unit.
The Native Antigen Company offers a range of reagents that enable research into vaccine development and diagnostics for emerging and endemic infectious diseases. Key product ranges include antigens, virus-like particles (VLPs), antibodies, BacTrace® antigens and antibodies, virus receptors, immunoassays, molecular controls, neutralization assay development kits, conjugation kits, and more.
All products listed on this site and sold through LAB-A-PORTER Limited are for research use only (RUO). Not for human use. Not for therapeutic or diagnostic use.